Lobbying client · LD-2 disclosures
Fulcrum Therapeutics
Massachusetts
6 filings from 1 registrant · 2025–2026 · latest filed Jul 20, 2026
Reported on its behalf
$270K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$270K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
6 filings
$270K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 1796 119th CongressSickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 20256 filingsthrough 2026
- S. 735 119th CongressSickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 20256 filingsthrough 2026
- H.R. 1262
Members whose bills were lobbied
Members of Congress whose sponsored or cosponsored bills were named in this client's lobbying filings from the same Congress, ranked by matched filings.
John JamesR-Michigan-AL
Bills: H.R. 1691, H.R. 1796, H.R. 2407 +6 more
84 filings
1 lobbyist
What this shows · A row here means a lobbying activity in this client's filings named a bill this member is on record sponsoring or cosponsoring in the same Congress — a bill-reference match, not a claim that the filing named the member's office. Bill numbers are reused every Congress, so the match is scoped to the Congress the filing was made under; a filing that cites an enacted law by its original bill number can therefore land on a later Congress's bill of the same number. Member names and bill references are cited as filed; both link to their own record once their sections leave beta.
Who did the lobbying
Every lobbyist named on this client's filings.
- John Mcmanus The Mcmanus Group7 filingsthrough 2026
- Lawren D Geer The Mcmanus Group4 filingsthrough 2025
- Abigail Smith The Mcmanus Group2 filingsthrough 2026
- Mary Grace Darcey The Mcmanus Group2 filingsthrough 2026
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: fulcrum-therapeutics.